These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 724575)

  • 1. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575
    [No Abstract]   [Full Text] [Related]  

  • 2. The evidence justifying immunosuppression therapy in multiple sclerosis.
    Mertin J
    Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of internal diseases using antilymphocyte globulin].
    Melli G; Mazzei D
    Munch Med Wochenschr; 1970 Mar; 112(12):523-6. PubMed ID: 4911635
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of multiple sclerosis with antilymphocyte serum: results of a pilot study on 50 patients followed-up over a 4-year period (author's transl)].
    Lhermitte F; Marteau R; De Saxce H
    Rev Neurol (Paris); 1979 Jun; 135(5):389-400. PubMed ID: 538387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive treatment of multiple sclerosis].
    Frick E
    Nervenarzt; 1976 Jul; 47(7):424-8. PubMed ID: 958545
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of antilymphocyte globulin in autoimmune nervous system diseases].
    Frick G; Preussner S; Perlberg KW
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):53-64. PubMed ID: 88390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
    Lance EM; Kremer M; Abbosh J; Jones VE; Knight S; Medawar PB
    Clin Exp Immunol; 1975 Jul; 21(1):1-12. PubMed ID: 1237376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.
    Knight SC; Lance EM; Abbosh J; Munro A; O'Brien J
    Clin Exp Immunol; 1975 Jul; 21(1):23-31. PubMed ID: 1181076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toleracne to equine IgG after immunosuppression in patients with multiple sclerosis.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Postgrad Med J; 1976; 52(5 Suppl):136-8. PubMed ID: 1033536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compatibility of antihuman lymphocyte globulin (AHLG). Possible side effects and complications].
    Preussner S; Frick G; Rudolph W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):37-52. PubMed ID: 88389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Immunosuppressive treatment of multiple sclerosis with ALG and/or thoracic duct drainage.
    Brendel W; Ring J; Seifert J
    Neurology; 1975 May; 25(5):490. PubMed ID: 1169712
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of intensive immunosuppression on the in vitro activity of lymphocytes from multiple sclerosis patients.
    Knight SC; Abbosh J; Lance EM
    Postgrad Med J; 1976; 52(5 Suppl):131-5. PubMed ID: 995783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.
    Ring J; Seifert J; Anstwurm H; Frick E; Mertin J; Brass B; Backmund H; Lob G
    Postgrad Med J; 1976; 52(5 Suppl):123-30. PubMed ID: 792844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis.
    Seland TP; Mc Pherson TA; Grace M; Lamoureux G; Blain JG
    Neurology; 1974 Jan; 24(1):34-40. PubMed ID: 4358999
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Clin Exp Immunol; 1975 Jul; 21(1):13-22. PubMed ID: 810281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J
    Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antilymphocyte globulin and adrenal steroids in the treatment of multiple sclerosis: short report based on seven cases.
    Cendrowski W
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):339-43. PubMed ID: 553516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive immunosuppression in the treatment of multiple sclerosis.
    Ring J; Seifert J; Lob G; Coulin K; Angstwurm H; Frick E; Brass B; Mertin J; Backmund H; Brendel W
    Lancet; 1974 Nov; 2(7889):1093-6. PubMed ID: 4139403
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Immunotherapy for multiple sclerosis.
    Br Med J; 1975 Nov; 4(5995):486-7. PubMed ID: 1192142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.